West Pharmaceutical Services, Inc. (BMV:WST)
4,435.00
0.00 (0.00%)
At close: Sep 23, 2025
BMV:WST Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 509.7 | 484.6 | 853.9 | 894.3 | 762.6 | 615.5 | Upgrade |
Cash & Short-Term Investments | 509.7 | 484.6 | 853.9 | 894.3 | 762.6 | 615.5 | Upgrade |
Cash Growth | 14.23% | -43.25% | -4.52% | 17.27% | 23.90% | 40.17% | Upgrade |
Accounts Receivable | 582.4 | 552.5 | 512 | 507.4 | 489 | 385.3 | Upgrade |
Inventory | 421.1 | 377 | 434.7 | 414.8 | 378.4 | 321.3 | Upgrade |
Other Current Assets | 167.7 | 124 | 135.8 | 103 | 112 | 51.6 | Upgrade |
Total Current Assets | 1,681 | 1,538 | 1,936 | 1,920 | 1,742 | 1,374 | Upgrade |
Net Property, Plant & Equipment | 1,826 | 1,686 | 1,513 | 1,263 | 1,127 | 1,012 | Upgrade |
Other Intangible Assets | 9.7 | 10.8 | 15.1 | 18.4 | 23 | 30.5 | Upgrade |
Goodwill | 110.9 | 106 | 108.5 | 107.3 | 109.9 | 111.1 | Upgrade |
Long-Term Investments | 224.7 | 202.1 | 210 | 204.9 | 207.7 | 214.7 | Upgrade |
Other Long-Term Assets | 100.2 | 100.3 | 47 | 104 | 104.4 | 52.3 | Upgrade |
Total Assets | 3,953 | 3,643 | 3,830 | 3,617 | 3,314 | 2,794 | Upgrade |
Accounts Payable | 239 | 239.3 | 242.4 | 215.4 | 232.2 | 213.1 | Upgrade |
Accrued Expenses | 93.4 | 73.5 | 105.9 | 76.8 | 116.3 | 106 | Upgrade |
Short-Term Debt | - | - | 134 | 2.2 | 44.2 | 2.3 | Upgrade |
Current Portion of Leases | 20.9 | 17.9 | 17.7 | 16 | 9.3 | 10.1 | Upgrade |
Other Current Liabilities | 251.3 | 219.7 | 171.8 | 208.6 | 192.1 | 171.9 | Upgrade |
Total Current Liabilities | 604.6 | 550.4 | 671.8 | 519 | 594.1 | 503.4 | Upgrade |
Long-Term Debt | 202.6 | 202.6 | 72.8 | 206.7 | 208.8 | 252.9 | Upgrade |
Long-Term Leases | 79.8 | 81.8 | 84.5 | 93 | 63 | 60.4 | Upgrade |
Other Long-Term Liabilities | 136.7 | 126.3 | 119.4 | 113.2 | 112.5 | 122.6 | Upgrade |
Total Long-Term Liabilities | 419.1 | 410.7 | 276.7 | 412.9 | 384.3 | 435.9 | Upgrade |
Total Liabilities | 1,024 | 961.1 | 948.5 | 931.9 | 978.4 | 939.3 | Upgrade |
Common Stock | 18.8 | 18.8 | 18.8 | 18.8 | 18.8 | 18.8 | Upgrade |
Treasury Stock | -1,140 | -1,057 | -637.6 | -370.9 | -229.5 | -167.7 | Upgrade |
Additional Paid-in Capital | - | 22.1 | 120.2 | 232.2 | 249 | 267.3 | Upgrade |
Accumulated Other Comprehensive Income | -88.7 | -258.1 | -143.8 | -183 | -159.6 | -110.6 | Upgrade |
Retained Earnings | 4,139 | 3,957 | 3,523 | 2,988 | 2,457 | 1,847 | Upgrade |
Shareholders' Equity | 2,929 | 2,682 | 2,881 | 2,685 | 2,335 | 1,855 | Upgrade |
Total Liabilities & Equity | 3,953 | 3,643 | 3,830 | 3,617 | 3,314 | 2,794 | Upgrade |
Total Debt | 303.3 | 302.3 | 309 | 317.9 | 325.3 | 325.7 | Upgrade |
Net Cash (Debt) | 206.4 | 182.3 | 544.9 | 576.4 | 437.3 | 289.8 | Upgrade |
Net Cash Growth | 13.22% | -66.54% | -5.46% | 31.81% | 50.90% | 163.93% | Upgrade |
Net Cash Per Share | 2.82 | 2.47 | 7.24 | 7.60 | 5.73 | 3.82 | Upgrade |
Book Value | 2,929 | 2,682 | 2,881 | 2,685 | 2,335 | 1,855 | Upgrade |
Book Value Per Share | 40.08 | 36.39 | 38.26 | 35.42 | 30.61 | 24.47 | Upgrade |
Tangible Book Value | 2,809 | 2,566 | 2,757 | 2,559 | 2,203 | 1,713 | Upgrade |
Tangible Book Value Per Share | 38.43 | 34.81 | 36.62 | 33.76 | 28.87 | 22.60 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.